missing translation for 'onlineSavingsMsg'
Learn More

Applied Biosystems™ TaqMan™ SARS-CoV-2 MS2 Assay 2.0

Catalog No. A51327
Encompass
Change view
Click to view available options
Quantity:
1000
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
A51327 1000
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. A51327 Supplier Applied Biosystems™ Supplier No. A51327

Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance.

The Applied Biosystems TaqMan SARS-CoV-2 with RNase P Assay 2.0 is a highly sensitive RT-PCR assay that reduces the risk of failure to detect SARS-CoV-2 with multiple target regions while compensating for emerging variants and mutations.

The Applied Biosystems TaqMan SARS-CoV-2 with RNase P Assay 2.0 includes an RNase P control and is used in combination with a control, control dilution buffer, and master mix for RT-PCR detection.

Features of the multiplex assay includes:

  • Targets multiple, non-overlapping, unique target regions of the SARS-CoV-2 ORF1a, ORF1b, and N genes
  • RNase P as a control to confirm a human sample

The TaqMan SARS-CoV-2 with RNase P Assay 2.0 can be used to evaluate up to 94 or 382 samples in under two hours. The assay can detect nucleic acid from SARS-CoV-2 in upper respiratory specimens such as nasopharyngeal and anterior nares samples from individuals suspected of SARS-CoV-2 infection. The assay can be used on Applied Biosystems real-time PCR systems including the QuantStudio 5 (96 well, 0.2 mL) or QuantStudio Flex (384-well) real-time PCR instruments. The assay results can be analyzed using Applied Biosystems Design and Analysis Software 2.5:

  • QuantStudio Design and Analysis Software 2.5 Windows Installer (.exe)
  • QuantStudio Design and Analysis Software 2.5 Mac Installer (.dmg)
  • QuantStudio Design and Analysis Software 2.5 Release Notes (.pdf)

The TaqMan SARS-CoV-2 with RNase P Assay 2.0 (1000 reactions) includes the multiplex assay with multiple primer/probe sets specific for different SARS-CoV-2 genomic regions and an RNase P control for confirmation of a human sample. The following components are used in combination with the assay (all available separately):

  • TaqMan SARS-CoV-2 Plus Control (Cat. No. 956129)—an RNA control that contains targets specific to the SARS-CoV-2 genomic regions targeted by the assay
  • TaqMan SARS-CoV-2 Control Dilution Buffer (Cat. No. A49889)—dilution buffer for RNA control
  • TaqPath 1-Step RT-qPCR Master Mix (No ROX) (Cat. No. A28523)

Specifications

Sample Type Nasopharyngeal, Anterior Nasal Swab
Sensitivity LoD of <250 GCE/Reaction
For Use With (Equipment) QuantStudio 5, QuantStudio 7
Quantity 1000
Test Time 90 min.

For Research Use Only. Not for use in diagnostic procedures.